Alkermes plc (ALKS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
43.56+0.70 (+1.63%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close42.86
Bid62.12 x 500
Ask62.55 x 100
Day's Range42.80 - 43.59
52wk Range27.14 - 80.71
1y Target EstN/A
Market Cap6.6B
P/E Ratio (ttm)-23.84
Avg Vol (3m)775,490
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal1 hour ago

    [$$] Business Watch

    Glencore PLC has agreed to sell its coal-haulage business in Australia’s New South Wales state to U.S. railroad operator Genesee & Wyoming Inc. for 1.14 billion Australian dollars (US$874 million), the ...

  • Forbes3 hours ago

    A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA

    Is the FDA really getting softer when it comes to drug approvals? How the agency handles the case of Alkermes' experimental antidepressant could be telling after the company reports a surprising success in a phase III trial following two crushing failures.

  • The Wall Street Journal4 hours ago

    [$$] Alkermes Shares Surge

    Alkermes PLC said its depression drug helped patients not responding to standard treatments, news that added more than $3 billion to the company’s market value in after-hours trading.